A real-world safety study found that patients treated with brolucizumab had low occurrences of intraocular inflammation, retinal vascular occlusion, and retinal vasculitis. A study published in ...

Inflammatory glaucoma, also known as uveitic glaucoma, is a complication of uveitis. It occurs when inflammation in the eye increases intraocular pressure and damages the optic nerve. Inflammatory ...

Patel, MD, PhD, of the University of Texas Southwestern Medical Center, breaks down QA102's first-in-class mechanism ...

Therini Bio, Inc., a clinical-stage biotech company developing fibrin-targeting immunotherapies for neurodegenerative diseases driven by vascular-mediated inflammation, today announced that the first ...

Researchers have developed an injectable inflammation-responsive hydrogel (IRH), which tests in mice showed can deliver an anti-inflammatory drug directly to the retina of the eye. Reporting on in ...

Researchers have developed new eye drops that have shown promising results in treating dry eye disease in experimental ...

Scientists have achieved a remarkable feat by enabling mouse eyes to perform part of the photosynthetic process using ...

With inflammation being the cause of dry eye in many cases, future treatment will likely target this aspect of dry eye. Yes, there are currently a lot of clinical trials focusing on new therapies for ...

In July, we reported on cases of unexplained ocular inflammation associated with pegcetacoplan (Syfovre), a treatment for geographic atrophy (GA) secondary to age-related macular degeneration (AMD).

A steroid alternative may offer a new way to treat dry eye by restoring the eye’s natural protective defenses.

Researchers at Baylor College of Medicine and Okayama University in Japan have developed and tested in mice a promising new ...